| Heather Bernice Boulting, ACNPC-AG | |
|
875 Blake Wilbur Dr, Palo Alto, CA 94304-2205 | |
| (650) 498-6000 | |
| Not Available |
| Full Name | Heather Bernice Boulting |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 875 Blake Wilbur Dr, Palo Alto, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043783830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 95010323 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Bernice Boulting, ACNPC-AG 3025 Argonaut Ave, Rocklin, CA 95677-1820 Ph: (530) 320-8040 | Heather Bernice Boulting, ACNPC-AG 875 Blake Wilbur Dr, Palo Alto, CA 94304-2205 Ph: (650) 498-6000 |
News Archive
Emisphere Technologies, Inc. today announced that an independent Data Monitoring Committee ("DMC") informed Novartis and its partner Nordic Bioscience about their recommendation to proceed with the Osteoporosis ("OP") Phase 3 Study 2303 and the Osteoarthritis ("OA") Phase 3 Study 2301 exploring the safety and efficacy of an oral formulation of salmon calcitonin to treat patients with osteoporosis and osteoarthritis of the knee.
Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.
The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Roche, PTC Therapeutics, Inc. and the SMA Foundation, announced today a licensing agreement for PTC's Spinal Muscular Atrophy (SMA) programme.
› Verified 4 days ago
Wendy Leigh Adams, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Mr. Christopher Gerard Gonzales, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3801 Miranda Ave, Emergency Department, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Sarah Davidson, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 212 High St, Palo Alto, CA 94301 Phone: 415-663-5584 | |
Erin Danielle Herse, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-736-7359 Fax: 650-497-8041 | |
Christian Laparan, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2977 | |
Theresa V Pittman, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Audrey Fong, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 Fax: 650-498-5840 |